2017. MULTIMODALITY TREATMENT OF GLIOBLASTOMA PATIENTS USING DIFFERENT TEMOZOLOMIDE REGIMENS IN POSTOPERATIVE CHEMORADIOTHERAPY. Voprosy onkologii. 63, 6 (Jun. 2017), 915–919. DOI:https://doi.org/10.37469/0507-3758-2017-63-6-915-919.